HER2 as a potential therapeutic target on quiescent prostate cancer cells.
Yumoto K, Rashid J, Ibrahim KG, Zielske SP, Wang Y, Omi M, Decker AM, Jung Y, Sun D, Remmer HA, Mishina Y, Buttitta LA, Taichman RS, Cackowski FC.
Yumoto K, et al. Among authors: remmer ha.
Transl Oncol. 2023 May;31:101642. doi: 10.1016/j.tranon.2023.101642. Epub 2023 Feb 18.
Transl Oncol. 2023.
PMID: 36805918
Free PMC article.